Degroof Petercam Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$16.9M Buy
608,665
+38,800
+7% +$1.08M 0.2% 90
2023
Q4
$16.4M Buy
+569,865
New +$17.2M 0.22% 97

Other funds holding PFE

Degroof Petercam Asset Management's PFE Position: Q1 2024 in Review

Degroof Petercam Asset Management increased its Pfizer (PFE) stake by 6.8% in Q1 2024, buying an estimated $1.08M and bringing the position to 608,665 shares worth $16.9M. The position accounts for 0.2% of the portfolio, ranked #90.

Degroof Petercam Asset Management first reported a position in PFE in Q4 2023 and has held it in 2 quarters since. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Degroof Petercam Asset Management held 608,665 shares of Pfizer worth $16.9M as of Q1 2024.
  • Degroof Petercam Asset Management bought 38,800 Pfizer shares in Q1 2024, an estimated $1.08M.
  • Pfizer made up 0.2% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #90 holding.
  • Degroof Petercam Asset Management first reported a position in Pfizer in Q4 2023 and has held it in 2 quarters since.
  • 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.